Wugen is a clinical-stage biotechnology company developing the next generation of off-the-shelf memory natural killer (NK) and CAR-T cell therapies for cancer. Wugen is leveraging its proprietary Moneta platform and deep genomic engineering expertise to pioneer a new class of memory NK cell therapies to treat hematological and solid tumor malignancies.
Wugen is based out of St. Louis, Missouri and San Diego, California.
Company Details
- Employees
- 66
- Founded
- -
- Address
- 4260 Forest Park Ave,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- wugen.com
- Keywords
- Biotechnology Research.
- HQ
- St. Louis, Missouri
Wugen Questions
Wugen's website is wugen.com
Wugen's LinkedIn profile is https://www.linkedin.com/company/wugen
Wugen has
66 employees.
View email and phone details for 66
employees at Wugen.
Wugen's industry is
Biotechnology Research
Wugen's categories are Biotechnology Research
Wugen's founding year is 2018
